// IP Marketing video - START// IP Marketing video - END

U.S. approves HIV-prevention drug

U.S. approves HIV-prevention drug

PanARMENIAN.Net - The U.S. has approved the first drug shown to reduce the risk of HIV infection, a milestone in the 30-year battle against the virus that causes Aids, Belfast Telegraph said.

The Food and Drug Administration approved Gilead Sciences' pill Truvada as a preventive measure for people who are at high risk of acquiring HIV, such as those who have sex with HIV-infected partners.

Gilead Sciences has marketed Truvada since 2004 as a treatment for people who are infected with the virus, but company studies have shown the drug can prevent people from contracting HIV when used as a precautionary measure.

A three-year study found that daily doses cut the risk of infection in healthy gay and bisexual men by 42%, when accompanied by condoms and counselling.

 Top stories
Tony’s tour guide for much of this journey is Serj Tankian, the Armenian-American lead singer of the metal band System of a Down.
Eduard Sharmazanov reminded that the Armenian parliament unanimously recognized the genocide of Greeks back in 2015.
So mass uprisings against corrupt rulers last week in Armenia ought to be celebrated as badly needed good news, the article says.
Lebanon’s leading hospitality and travel portal, is currently in Armenia with a mission to discover the country’s tasty corners.
Partner news